HPGDS and Duchenne muscular dystrophy: These findings underscore the critical role of PGD2 in the pathophysiology of DMD and highlight the efficacy of targeted intervention strategies that disrupt this pathway (e.g., using PK007), offering a promising avenue for future treatments to reduce disease severity (and help maintain muscle mass) in young DMD boys.